Blog

Irritable bowel syndrome with constipation (IBS-C) presents a persistent challenge of infrequent, difficult bowel movements paired with abdominal pain

Evidence-Based Management of IBS-C: New Insights from 2026 Research Irritable bowel syndrome with constipation dominates symptoms for a substantial numb…

Dietary Fiber, Gut Motility, and Constipation: New Mechanisms Revealed A 2026 study from Jiangnan University provides a detailed look at how one specifi…

Introduction A 2026 nationwide study involving three-gas breath testing identified hydrogen sulfide (H 2 S) as a microbial gas strongly associated with …

IBS-C Constipation: A Pathophysiology-Driven Management Approach Irritable bowel syndrome with constipation (IBS-C) involves more than slow transit

Introduction Treatment for irritable bowel syndrome with constipation (IBS-C) is moving beyond symptom management

A Double-Edged Sword: Recovery and Resistance After Antibiotics Two 2026 studies reveal a complex picture of gut microbiome recovery following medical t…

Pathophysiology-Driven IBS-C Management: Moving Beyond Single-Target Laxatives Irritable Bowel Syndrome with Constipation (IBS-C) affects millions, yet …

Short-Chain Fatty Acid Depletion Links Gut Dysbiosis to Systemic Disease New research reveals that a deficit of specific gut bacteria and their metaboli…

Introduction A 2026 review by Mohamed et al

New Review Outlines a Pathophysiology-Driven Strategy for IBS-C Using Natural Products A 2026 review from researchers at Heliopolis and Cairo Universiti…

Irritable bowel syndrome with constipation (IBS-C) is a complex disorder where treatment often requires more than just fiber or laxatives